triple action glp 1 🧬 The Evolution of Weight Loss: Meet the Agonist. 🧪 We've seen GLP- (Semaglutide) and dual-acting GLP-1/GIP (Tirzepatide) change lives. Now, Retatrutide is taking it to the next level. By adding Transforming obesity: The advancement of

Compared with other second- or third-line glucose-lowering medications, the GLP-1RAs demonstrated a lower rate of adverse CVEs, including heart failure (HR 0.88

As we await prospective data, clinical practice should consider the difference between abrupt stop vs gradual taper when counseling patients about expectations after therapy

Learn what to expect from compounded GLP-1 injections here.

Lowers the risk of kidney disease

Taking antibiotics while on semaglutide requires understanding potential interactions and timing strategies to protect both your infection treatment and weight loss progress

Discover evidence-based techniques to reduce bruising, improve injection comfort, and get the most from your semaglutide treatment